RSS Feeds
Cystatin C, Renal Function, and Cardiovascular Risk
- Vandana Menon, MD, PhD;
- Mark J. Sarnak, MD, MS; and
- Michael G. Shlipak, MD, MPH
- From Tufts-New England Medical Center, Boston, MA 02111, and Veterans Affairs Medical Center, San Francisco, CA 94121.
IN RESPONSE:
Regarding our analyses examining cystatin C as a risk factor for outcomes in chronic kidney disease, we do not make the assertion that cystatin C is better than creatinine in diagnosing stage 3 kidney disease. Regarding the question about our methods, cystatin C was measured in frozen samples collected at baseline from participants of the randomized cohort of the Modification of Diet in Renal Disease Study, as stated in the Methods section. There is a precedent for using frozen stored samples to analyze cystatin C (1–3). Serum and plasma samples stored …
This 100-word excerpt has been provided in the absence of an abstract.
